Alivus Life

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE03Q201024
  • NSEID: ALIVUS
  • BSEID: 543322
INR
861.30
-7.05 (-0.81%)
BSENSE

Jan 21

BSE+NSE Vol: 1.13 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAlivus Life VS Pharmaceuticals & Biotechnology
 
1D
-0.81%
-0.3%
1W
-3.07%
-1.98%
1M
-4.37%
-3.12%
YTD
-6.03%
-3.72%
1Y
-25.1%
9.26%
3Y
115.08%
39.55%
5Y
%
72.43%
10Y
%
245.72%
  • Stock Absolute Returns
  • Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.58%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.83%
0%
-6.83%
6 Months
-18.53%
0.49%
-18.04%
1 Year
-25.1%
0.42%
-24.68%
2 Years
7.86%
0.58%
8.44%
3 Years
115.08%
12.94%
128.02%
4 Years
45.22%
10.85%
56.07%
5 Years
0%
0%
0.0%

Latest dividend: 5 per share ex-dividend date: Sep-01-2025

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Alivus Life Sciences Ltd has not been a consistent performer in the last 1 year and longer periods

3
Quartile
quartile-3
QTD
-5.26%
2
Quartile
quartile-2
Sep-Dec
-1.35%
3
Quartile
quartile-3
Jun-Sep
-7.6%
4
Quartile
quartile-4
1Y
-24.48%
2
Quartile
quartile-2
2025
-6.8%
3
Quartile
quartile-3
2024
49.68%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Alivus Life Sciences Ltd has not been a consistent performer in the last 1 year and longer periods

2
Quartile
quartile-2
QTD
-5.26%
2
Quartile
quartile-2
Sep-Dec
-1.35%
3
Quartile
quartile-3
Jun-Sep
-7.6%
3
Quartile
quartile-3
1Y
-24.48%
2
Quartile
quartile-2
2025
-6.8%
2
Quartile
quartile-2
2024
49.68%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Alivus Life Sciences Ltd has not been a consistent performer in the last 1 year and longer periods

2
Quartile
quartile-2
QTD
-5.26%
2
Quartile
quartile-2
Sep-Dec
-1.35%
3
Quartile
quartile-3
Jun-Sep
-7.6%
3
Quartile
quartile-3
1Y
-24.48%
2
Quartile
quartile-2
2025
-6.8%
2
Quartile
quartile-2
2024
49.68%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available